Suspension of trading

Income Statement Atrion Corporation

Stocks

ATRI

US0499041053

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 16:00:00 2024-08-20 EDT			5-day change	1st Jan Change
459.92 ^USD	+0.06%		-.--%	-

24-08-22	Atrion Corporation(NasdaqGS:ATRI) dropped from S&P Healthcare Equipment Select Industry Index	CI
24-08-22	Atrion Corporation(NasdaqGS:ATRI) dropped from S&P TMI Index	CI

a4347b91854c9103f50195fcd1faaeb.XsgPF9_jq-yYf_erzlG0lExnjx5JE4bYUOPa2BeUPzs.D55HZbOn5qfWDrzSl2LioHge6jM8WO6WZbadt1jxTA0nuFAjjoXo3KoTrg

Published financial data: ATRION CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	155M	148M	165M	184M	169M
Total Revenues	155M	148M	165M	184M	169M
Cost of Goods Sold, Total	84.38M	81.43M	95.64M	108M	107M
Gross Profit	70.69M	66.16M	69.37M	75.9M	62.39M
Selling General & Admin Expenses, Total	25.12M	24.85M	27.66M	30.72M	33.12M
R&D Expenses	5.04M	5.64M	5.67M	5.5M	6.69M
Other Operating Expenses, Total	30.16M	30.5M	33.33M	36.22M	39.81M
Operating Income	40.53M	35.67M	36.04M	39.69M	22.58M
Interest Expense, Total	-	-	-	-	-149K
Interest And Investment Income	2.64M	2.8M	2.32M	988K	806K
Net Interest Expenses	2.64M	2.8M	2.32M	988K	657K
Other Non Operating Income (Expenses)	-	-	67K	92K	39K
EBT, Excl. Unusual Items	43.17M	38.47M	38.43M	40.77M	23.28M
Gain (Loss) On Sale Of Investments	-	-	-	-150K	-900K
EBT, Incl. Unusual Items	43.17M	38.47M	38.43M	40.62M	22.38M
Income Tax Expense	6.41M	6.35M	5.37M	5.61M	2.96M
Earnings From Continuing Operations	36.76M	32.12M	33.06M	35.01M	19.41M
Net Income to Company	36.76M	32.12M	33.06M	35.01M	19.41M
Net Income - (IS)	36.76M	32.12M	33.06M	35.01M	19.41M
Net Income to Common Incl Extra Items	36.76M	32.12M	33.06M	35.01M	19.41M
Net Income to Common Excl. Extra Items	36.76M	32.12M	33.06M	35.01M	19.41M
Per Share Items
Net EPS - Basic	19.82	17.49	18.22	19.59	11.02
Basic EPS - Continuing Operations	19.82	17.49	18.22	19.59	11.02
Basic Weighted Average Shares Outstanding	1.86M	1.84M	1.81M	1.79M	1.76M
Net EPS - Diluted	19.73	17.44	18.18	19.56	11.02
Diluted EPS - Continuing Operations	19.73	17.44	18.18	19.56	11.02
Diluted Weighted Average Shares Outstanding	1.86M	1.84M	1.82M	1.79M	1.76M
Normalized Basic EPS	14.54	13.09	13.24	14.26	8.26
Normalized Diluted EPS	14.48	13.06	13.21	14.23	8.26
Dividend Per Share	5.8	6.6	7.4	8.2	8.7
Payout Ratio	29.26	37.68	40.56	41.76	78.88
Supplemental Items
EBITDA	51.38M	47.32M	48.93M	53.5M	37.68M
EBITA	40.65M	35.79M	36.16M	39.8M	22.69M
EBIT	40.53M	35.67M	36.04M	39.69M	22.58M
Effective Tax Rate - (Ratio)	14.84	16.51	13.98	13.81	13.25
Current Domestic Taxes	4.6M	4.07M	9.06M	8.8M	4.48M
Total Current Taxes	4.6M	4.07M	9.06M	8.8M	4.48M
Deferred Domestic Taxes	1.81M	2.28M	-3.69M	-3.19M	-1.52M
Total Deferred Taxes	1.81M	2.28M	-3.69M	-3.19M	-1.52M
Normalized Net Income	26.98M	24.04M	24.02M	25.48M	14.55M
Interest on Long-Term Debt	-	-	-	-	149K
Supplemental Operating Expense Items
Selling and Marketing Expenses	8.81M	7.52M	8.06M	9.78M	9.93M
General and Administrative Expenses	16.31M	17.33M	19.6M	20.94M	23.19M
Research And Development Expense From Footnotes	5.04M	5.64M	5.67M	5.5M	6.69M
Stock-Based Comp., G&A Exp. (Total)	1.68M	1.73M	2.31M	1.73M	1.53M
Total Stock-Based Compensation	1.68M	1.73M	2.31M	1.73M	1.53M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	45.05M	22.45M	32.26M	4.73M	3.56M
Short Term Investments	23.77M	19.26M	29.06M	21.15M	2.69M
Total Cash And Short Term Investments	68.81M	41.71M	61.32M	25.88M	6.26M
Accounts Receivable, Total	18.89M	16.44M	21.02M	23.95M	23.03M
Other Receivables	4K	1.52M	345K	1M	-
Total Receivables	18.89M	17.97M	21.37M	24.95M	23.03M
Inventory	42.09M	50.3M	50.78M	65.79M	82.31M
Prepaid Expenses	2.54M	2.34M	3.1M	2.77M	3.17M
Deferred Tax Assets Current	-	-	-	-	-
Total Current Assets	132M	112M	137M	119M	115M
Gross Property Plant And Equipment	201M	219M	233M	271M	286M
Accumulated Depreciation	-116M	-124M	-135M	-147M	-161M
Net Property Plant And Equipment	84.61M	94.94M	97.97M	124M	125M
Long-term Investments	31.77M	46.21M	19.42M	8.67M	8.16M
Goodwill	9.73M	9.73M	9.73M	9.73M	9.73M
Other Intangibles, Total	1.54M	1.42M	1.3M	1.18M	1.07M
Deferred Charges Long-Term	2.05M	2.28M	2.27M	1.98M	1.75M
Total Assets	262M	267M	267M	265M	261M
Liabilities
Accounts Payable, Total	5.71M	6.64M	7.15M	12.07M	6.63M
Accrued Expenses, Total	4.85M	6.31M	5.93M	5.95M	5.89M
Current Portion of Leases	299K	251K	-	-	-
Current Income Taxes Payable	419K	436K	270K	74K	106K
Total Current Liabilities	11.27M	13.64M	13.35M	18.1M	12.62M
Long-Term Leases	268K	21K	90K	672K	240K
Deferred Tax Liability Non Current	8.5M	10.77M	7.08M	3.89M	2.37M
Other Non Current Liabilities	4.12M	2.02M	2.45M	2.51M	2.7M
Total Liabilities	24.16M	26.45M	22.97M	25.17M	17.94M
Common Stock, Total	342K	342K	342K	342K	342K
Additional Paid In Capital	52.04M	53.53M	61.17M	66.35M	67.33M
Retained Earnings	318M	338M	357M	378M	382M
Treasury Stock	-132M	-151M	-175M	-205M	-207M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	238M	240M	244M	240M	243M
Total Equity	238M	240M	244M	240M	243M
Total Liabilities And Equity	262M	267M	267M	265M	261M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.85M	1.83M	1.8M	1.76M	1.76M
ECS Total Common Shares Outstanding	1.86M	1.83M	1.8M	1.76M	1.76M
Book Value / Share	128.23	131.68	135.64	136.03	138.01
Tangible Book Value	227M	229M	233M	229M	232M
Tangible Book Value Per Share	122.16	125.57	129.52	129.83	131.87
Total Debt	567K	272K	90K	672K	240K
Net Debt	-68.25M	-41.44M	-61.23M	-25.21M	-6.02M
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.27M	1.54M	2.03M	2.36M	2.57M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	18.16M	20.31M	23.73M	33.33M	37.77M
Inventories - Work In Process, Total	8.52M	11.34M	9.57M	13.62M	17.46M
Inventories - Finished Goods, Total	15.41M	18.65M	17.47M	18.85M	27.08M
Land - (BS)	5.51M	5.51M	5.51M	5.51M	5.51M
Buildings, Total	34.58M	35.11M	35.3M	60.98M	66.19M
Machinery, Total	161M	178M	192M	204M	215M
Full Time Employees	616	636	667	722	712
Accumulated Allowance for Doubtful Accounts (Supple)	36K	41K	69K	71K	58K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	36.76M	32.12M	33.06M	35.01M	19.41M
Depreciation & Amortization - CF	10.73M	11.53M	12.77M	13.7M	14.98M
Amortization of Goodwill and Intangible Assets - (CF)	119K	119K	119K	117K	113K
Depreciation & Amortization, Total	10.85M	11.65M	12.88M	13.81M	15.1M
(Gain) Loss on Sale of Investments - (CF)	-135K	-1.09M	-1.47M	89K	900K
Stock-Based Compensation (CF)	1.68M	1.73M	2.31M	1.73M	1.53M
Other Operating Activities, Total	1.52M	2.16M	-3.03M	-3.08M	-1.64M
Change In Accounts Receivable	-1.87M	2.44M	-4.58M	-2.93M	922K
Change In Inventories	-8.52M	-8.2M	-480K	-15.02M	-16.51M
Change In Accounts Payable	1.25M	2.1M	-656K	-1.25M	-326K
Change In Income Taxes	-200K	17K	-165K	-196K	32K
Change in Other Net Operating Assets	1.12M	-3.94M	930K	611K	587K
Cash from Operations	42.46M	38.97M	38.8M	28.79M	20.01M
Capital Expenditure	-20.45M	-21.89M	-15.83M	-33.74M	-22.32M
Investment in Marketable and Equity Securities, Total	-24.39M	-8.95M	17.82M	18.45M	18.18M
Cash from Investing	-44.84M	-30.83M	2M	-15.28M	-4.14M
Short Term Debt Issued, Total	-	-	-	607K	25.61M
Total Debt Issued	-	-	-	607K	25.61M
Short Term Debt Repaid, Total	-	-	-	-607K	-25.61M
Total Debt Repaid	-	-	-	-607K	-25.61M
Repurchase of Common Stock	-579K	-18.89M	-17.57M	-26.42M	-1.72M
Common Dividends Paid	-10.76M	-12.1M	-13.41M	-14.62M	-15.31M
Common & Preferred Stock Dividends Paid	-10.76M	-12.1M	-13.41M	-14.62M	-15.31M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-11.33M	-30.99M	-30.98M	-41.04M	-17.04M
Miscellaneous Cash Flow Adjustments	-	250K	-	-	-
Net Change in Cash	-13.7M	-22.6M	9.81M	-27.53M	-1.17M
Supplemental Items
Cash Income Tax Paid (Refund)	4.18M	5.56M	7.74M	9.88M	3.54M
Levered Free Cash Flow	8.48M	8.81M	16.97M	-6.9M	-12.14M
Unlevered Free Cash Flow	8.48M	8.81M	16.97M	-6.9M	-12.05M
Change In Net Working Capital	8.94M	4.98M	4.93M	13.51M	20.47M
Net Debt Issued / Repaid	-	-	-	0	0

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	10.27	8.43	8.43	9.33	5.37
Return on Total Capital	11.28	9.32	9.29	10.24	5.85
Return On Equity %	16.39	13.43	13.64	14.47	8.05
Return on Common Equity	16.39	13.43	13.64	14.47	8.05
Margin Analysis
Gross Profit Margin %	45.59	44.83	42.04	41.36	36.84
SG&A Margin	16.2	16.84	16.76	16.74	19.56
EBITDA Margin %	33.14	32.06	29.65	29.15	22.25
EBITA Margin %	26.21	24.25	21.91	21.69	13.4
EBIT Margin %	26.14	24.17	21.84	21.63	13.33
Income From Continuing Operations Margin %	23.71	21.76	20.03	19.08	11.46
Net Income Margin %	23.71	21.76	20.03	19.08	11.46
Net Avail. For Common Margin %	23.71	21.76	20.03	19.08	11.46
Normalized Net Income Margin	17.4	16.29	14.56	13.88	8.59
Levered Free Cash Flow Margin	5.47	5.97	10.28	-3.76	-7.17
Unlevered Free Cash Flow Margin	5.47	5.97	10.28	-3.76	-7.12
Asset Turnover
Asset Turnover	0.63	0.56	0.62	0.69	0.64
Fixed Assets Turnover	1.94	1.64	1.71	1.66	1.36
Receivables Turnover (Average Receivables)	8.64	8.35	8.81	8.16	7.21
Inventory Turnover (Average Inventory)	2.23	1.76	1.89	1.85	1.44
Short Term Liquidity
Current Ratio	11.74	8.24	10.23	6.6	9.09
Quick Ratio	7.78	4.38	6.2	2.81	2.32
Operating Cash Flow to Current Liabilities	3.77	2.86	2.91	1.59	1.59
Days Sales Outstanding (Average Receivables)	42.25	43.81	41.44	44.73	50.63
Days Outstanding Inventory (Average Inventory)	163.65	207.64	192.88	197.71	252.75
Average Days Payable Outstanding	21.19	25.2	26.17	28.61	27.65
Cash Conversion Cycle (Average Days)	184.71	226.25	208.15	213.83	275.73
Long Term Solvency
Total Debt/Equity	0.24	0.11	0.04	0.28	0.1
Total Debt / Total Capital	0.24	0.11	0.04	0.28	0.1
LT Debt/Equity	0.11	0.01	0.04	0.28	0.1
Long-Term Debt / Total Capital	0.11	0.01	0.04	0.28	0.1
Total Liabilities / Total Assets	9.22	9.91	8.59	9.51	6.88
EBIT / Interest Expense	-	-	-	-	151.54
EBITDA / Interest Expense	-	-	-	-	252.87
(EBITDA - Capex) / Interest Expense	-	-	-	-	103.07
Total Debt / EBITDA	0.01	0.01	0	0.01	0.01
Net Debt / EBITDA	-1.33	-0.88	-1.25	-0.47	-0.16
Total Debt / (EBITDA - Capex)	0.02	0.01	0	0.03	0.02
Net Debt / (EBITDA - Capex)	-2.21	-1.63	-1.85	-1.28	-0.39
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.72	-4.82	11.8	11.21	-7.73
Gross Profit, 1 Yr. Growth %	-1.52	-6.4	4.85	9.42	-17.81
EBITDA, 1 Yr. Growth %	1.09	-7.91	3.4	9.34	-29.57
EBITA, 1 Yr. Growth %	-2.82	-11.96	1.04	10.07	-42.99
EBIT, 1 Yr. Growth %	-2.82	-11.99	1.05	10.11	-43.11
Earnings From Cont. Operations, 1 Yr. Growth %	7.32	-12.64	2.93	5.91	-44.55
Net Income, 1 Yr. Growth %	7.32	-12.64	2.93	5.91	-44.55
Normalized Net Income, 1 Yr. Growth %	-0.57	-10.89	-0.1	6.08	-42.91
Diluted EPS Before Extra, 1 Yr. Growth %	7	-11.61	4.24	7.59	-43.66
Accounts Receivable, 1 Yr. Growth %	11	-12.92	27.84	13.93	-3.85
Inventory, 1 Yr. Growth %	25.38	19.49	0.95	29.57	25.1
Net Property, Plant and Equip., 1 Yr. Growth %	12.97	12.21	3.2	26.32	1.29
Total Assets, 1 Yr. Growth %	13.33	1.85	0.14	-0.95	-1.47
Tangible Book Value, 1 Yr. Growth %	13.65	1.19	1.73	-1.99	1.51
Common Equity, 1 Yr. Growth %	12.86	1.08	1.6	-1.95	1.4
Cash From Operations, 1 Yr. Growth %	-1.78	-8.23	-1.08	-25.8	-30.51
Capital Expenditures, 1 Yr. Growth %	16.79	7.04	-27.68	113.14	-33.84
Levered Free Cash Flow, 1 Yr. Growth %	-46.14	0.41	87.19	-140.69	75.9
Unlevered Free Cash Flow, 1 Yr. Growth %	-46.14	0.41	87.19	-140.69	74.55
Dividend Per Share, 1 Yr. Growth %	13.73	13.79	12.12	10.81	6.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.85	-1.61	3.16	11.51	1.3
Gross Profit, 2 Yr. CAGR %	-0.05	-3.99	-0.94	7.11	-5.17
EBITDA, 2 Yr. CAGR %	1.42	-3.51	-2.42	6.33	-12.25
EBITA, 2 Yr. CAGR %	-0.94	-7.37	-5.54	5.64	-20.65
EBIT, 2 Yr. CAGR %	-0.91	-7.52	-5.7	5.48	-20.85
Earnings From Cont. Operations, 2 Yr. CAGR %	0.23	-3.17	-5.17	4.41	-23.37
Net Income, 2 Yr. CAGR %	0.23	-3.17	-5.17	4.41	-23.37
Normalized Net Income, 2 Yr. CAGR %	0.97	-5.87	-5.65	2.95	-22.18
Diluted EPS Before Extra, 2 Yr. CAGR %	0.05	-2.75	-4.01	5.9	-22.14
Accounts Receivable, 2 Yr. CAGR %	5.17	-1.69	5.51	20.68	4.66
Inventory, 2 Yr. CAGR %	19.75	22.4	9.83	14.37	27.32
Net Property, Plant and Equip., 2 Yr. CAGR %	12.91	12.59	7.61	14.17	13.11
Total Assets, 2 Yr. CAGR %	13.4	7.44	0.99	-0.41	-1.21
Tangible Book Value, 2 Yr. CAGR %	14.49	7.24	1.46	-0.15	-0.25
Common Equity, 2 Yr. CAGR %	13.58	6.81	1.34	-0.19	-0.29
Cash From Operations, 2 Yr. CAGR %	-4.98	-5.06	-4.42	-14.32	-28.19
Capital Expenditures, 2 Yr. CAGR %	45.36	11.81	-12.02	24.15	18.75
Levered Free Cash Flow, 2 Yr. CAGR %	-43.63	-25.17	39.04	-12.73	-15.4
Unlevered Free Cash Flow, 2 Yr. CAGR %	-43.63	-25.17	39.04	-12.73	-15.73
Dividend Per Share, 2 Yr. CAGR %	13.53	13.76	12.95	11.46	8.43
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.62	0.23	2.67	5.77	4.69
Gross Profit, 3 Yr. CAGR %	1.48	-2.21	-1.13	2.4	-1.94
EBITDA, 3 Yr. CAGR %	2.24	-1.79	-1.26	1.35	-7.31
EBITA, 3 Yr. CAGR %	1.05	-4.76	-4.64	-0.6	-13.99
EBIT, 3 Yr. CAGR %	1.18	-4.75	-4.75	-0.7	-14.14
Earnings From Cont. Operations, 3 Yr. CAGR %	10.05	-4.26	-1.18	-1.62	-15.45
Net Income, 3 Yr. CAGR %	10.05	-4.26	-1.18	-1.62	-15.45
Normalized Net Income, 3 Yr. CAGR %	2.94	-3.15	-3.99	-1.89	-15.42
Diluted EPS Before Extra, 3 Yr. CAGR %	9.93	-4	-0.47	-0.29	-14.19
Accounts Receivable, 3 Yr. CAGR %	3.23	-1.25	7.31	8.24	11.88
Inventory, 3 Yr. CAGR %	13.2	19.66	14.79	16.05	17.84
Net Property, Plant and Equip., 3 Yr. CAGR %	9.04	12.67	9.37	13.51	9.71
Total Assets, 3 Yr. CAGR %	12.93	9.41	4.95	0.34	-0.76
Tangible Book Value, 3 Yr. CAGR %	14.41	9.87	5.37	0.3	0.4
Common Equity, 3 Yr. CAGR %	13.43	9.25	5.04	0.23	0.34
Cash From Operations, 3 Yr. CAGR %	4.32	-6.08	-3.55	-12.15	-20.1
Capital Expenditures, 3 Yr. CAGR %	24.33	31.26	-3.3	18.17	0.66
Levered Free Cash Flow, 3 Yr. CAGR %	-29.92	-30.87	2.53	-7.69	10.24
Unlevered Free Cash Flow, 3 Yr. CAGR %	-29.92	-30.87	2.53	-7.69	9.96
Dividend Per Share, 3 Yr. CAGR %	14.14	13.62	13.21	12.24	9.65
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.95	0.25	2.83	4.59	2.12
Gross Profit, 5 Yr. CAGR %	0.63	-1.4	0.51	1.42	-2.77
EBITDA, 5 Yr. CAGR %	0.73	-1.61	0.35	1.38	-5.81
EBITA, 5 Yr. CAGR %	-0.21	-3.54	-1.7	-0.8	-11.46
EBIT, 5 Yr. CAGR %	-0.14	-3.45	-1.63	-0.78	-11.55
Earnings From Cont. Operations, 5 Yr. CAGR %	5.74	2.11	3.69	-0.88	-10.74
Net Income, 5 Yr. CAGR %	5.74	2.11	3.69	-0.88	-10.74
Normalized Net Income, 5 Yr. CAGR %	0.54	-2.33	-0.59	-0.75	-11.72
Diluted EPS Before Extra, 5 Yr. CAGR %	6.98	2.43	4.13	-0.15	-9.78
Accounts Receivable, 5 Yr. CAGR %	2.17	-0.21	4.14	7	6.24
Inventory, 5 Yr. CAGR %	8.48	11.06	11.84	17.52	19.64
Net Property, Plant and Equip., 5 Yr. CAGR %	6.24	8.44	8.46	13.27	10.85
Total Assets, 5 Yr. CAGR %	8.85	10.18	7.99	5.37	2.44
Tangible Book Value, 5 Yr. CAGR %	10.54	11.65	9.04	5.75	3.08
Common Equity, 5 Yr. CAGR %	9.72	10.78	8.43	5.37	2.88
Cash From Operations, 5 Yr. CAGR %	6.34	-0.73	0.74	-9.35	-14.28
Capital Expenditures, 5 Yr. CAGR %	10.04	18.61	8.27	28.37	4.98
Levered Free Cash Flow, 5 Yr. CAGR %	-13.47	-20.45	-7.18	-23.69	-5.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	-13.47	-20.45	-7.18	-23.69	-5.2
Dividend Per Share, 5 Yr. CAGR %	15.84	14.87	13.67	12.75	11.27